Daily as of 3 Nov 16:00 ET
- Price
- above both $32.25 vs 50 $27.56 / 200 $31.76
- Projection
- 🟨Golden cross estimated in 17 to 24 bars
- Test
- No active test
- Last cross
- 💀Death cross 19 May 2026 · projected 30 bars out
MAZE | Maze TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$32.25
+$1.88 (+6.19%)
Maze Therapeutics (MAZE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since May 2026, but the two have been closing on each other and a golden cross is projected within 30 bars. Price sits above the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- above both $32.25 vs 50 $28.95 / 200 $27.85
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 23 Oct 2026 · projected 10 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 23 Oct 2026 | 🟨Golden | 4-hour | 10 bars out | Not tested |
| 17 Sep 2026 | 💀Death | 4-hour | 27 bars out | 1 bar cross test |
| 19 May 2026 | 💀Death steep | daily | 30 bars out | Not tested |
About MAZE
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2026
SectorHealthcare
Cap bandsmall